Orchestra BioMed Holdings Inc (NASDAQ: OBIO) on Tuesday, soared 10.54% from the previous trading day, before settling in for the closing price of $4.84. Within the past 52 weeks, OBIO’s price has moved between $2.20 and $6.30.
A company in the Healthcare sector has dropped its sales by -273.68% annually for the last half of the decade. The company achieved an average annual earnings per share of -5.65%. With a float of $43.33 million, this company’s outstanding shares have now reached $56.46 million.
Orchestra BioMed Holdings Inc (OBIO) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Orchestra BioMed Holdings Inc is 23.27%, while institutional ownership is 40.60%. The most recent insider transaction that took place on Nov 14 ’25, was worth 20,350. In this transaction an insider of this company bought 5,000 shares at a rate of $4.07, taking the stock ownership to the 612,822 shares. Before that another transaction happened on Sep 19 ’25, when Company’s Director bought 1,000 for $2.45, making the entire transaction worth $2,450. This insider now owns 108,482 shares in total.
Orchestra BioMed Holdings Inc (OBIO) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.43 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.42) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.29% during the next five years compared to -273.68% drop over the previous five years of trading.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Trading Performance Indicators
Orchestra BioMed Holdings Inc (OBIO) is currently performing well based on its current performance indicators. A quick ratio of 4.72 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 107.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.82, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.57 in one year’s time.
Technical Analysis of Orchestra BioMed Holdings Inc (OBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.46 million. That was better than the volume of 0.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 89.00%.
During the past 100 days, Orchestra BioMed Holdings Inc’s (OBIO) raw stochastic average was set at 98.44%, which indicates a significant increase from 97.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.41 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.49, while its 200-day Moving Average is $3.32. However, in the short run, Orchestra BioMed Holdings Inc’s stock first resistance to watch stands at $5.62. Second resistance stands at $5.89. The third major resistance level sits at $6.38. If the price goes on to break the first support level at $4.86, it is likely to go to the next support level at $4.37. Assuming the price breaks the second support level, the third support level stands at $4.10.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Key Stats
Market capitalization of the company is 302.09 million based on 56,465K outstanding shares. Right now, sales total 2,640 K and income totals -61,020 K. The company made 860 K in profit during its latest quarter, and -20,830 K in sales during its previous quarter.
